Navigation Links
Protein signal is crucial for accurate control of insect size
Date:5/4/2012

to recovery from injury and cancer," said Dominguez.

EMBO Member Pierre Lopold and collaborators from the Institute of Biology Valrose at the University of Nice, France, identified the same protein using a different experimental approach. "We used a genome-wide RNA interference approach to look for Drosophila gene candidates that might be involved in coupling growth with the timing of development. Out of 11,000 genes that we tested in our genetic screen, only one was able, upon silencing, to rescue the delay in development induced by conditions that perturb tissue growth. This candidate gene corresponded to dilp8, which is exactly same gene identified by Dominguez and collaborators."

The expression of the dilp8 gene reduces tissue growth, which suggests that in addition to its role in preventing the hormonal induction of metamorphosis, dilp8 could act by slowing the growth of healthy tissues to stay synchronized with slow-growing tissue.

Until now, little information at the molecular level has been available about how organ growth is monitored and coordinated with the timing of development in insects and other complex organisms. Dilp8 appears to be part of the molecular machinery that helps tissues to grow and develop at the right pace.


'/>"/>

Contact: Barry Whyte
barry.whyte@embo.org
49-622-188-91108
European Molecular Biology Organization
Source:Eurekalert  

Page: 1 2

Related biology news :

1. Key proteins newly discovered form and function may provide novel cancer treatment target
2. In protein folding, internal friction may play a more significant role than previously thought
3. High levels of TRAIL protein in breast milk might contribute to anticancer activity
4. New study finds a protein combination is best to consume post-workout for building muscle
5. HUNT Biosciences and SomaLogic collaborate to validate protein biomarkers of cardiovascular risk
6. Researchers identified a protein useful in predicting the risk of pulmonary metastases in breast cancer patients
7. Newly found protein helps cells build tissues
8. Plant research reveals new role for gene silencing protein
9. Protein jailbreak helps breast cancer cells live
10. New hope for treating Alzheimers Disease: A role for the FKBP52 protein
11. The Japanese traditional therapy, honokiol, blocks key protein in inflammatory brain damage
Post Your Comments:
*Name:
*Comment:
*Email:
Related Image:
Protein signal is crucial for accurate control of insect size
(Date:8/12/2015)... , Aug. 12, 2015   MedNet Solutions ... the entire spectrum of clinical research, is proud to ... the company,s comprehensive SaaS-based eClinical technology platform, has led ... the first two quarters of 2015.   Q2 2015 ... largest quarters measured by contract value sold in the ...
(Date:8/12/2015)... Aug. 12, 2015  New research unveiled at ... Android phones to steal users, fingerprints. Information released ... of fingerprint scanners on mobile devices, making the ... secure biometrics on mobile devices, HYPR Corp. recently ... convenient authentication systems with strong cryptographic security. More ...
(Date:8/11/2015)... -- Today, ZUK announced its Android smartphone Z1, featuring ... revenues in 2015 that relate to sales of FPC1155 for this ... 2,200 MSEK for 2015. Jörgen Lantto, CEO of FPC, ... smartphone manufacturer in China and we ... 155 for Z1 , ...
Breaking Biology News(10 mins):MedNet Solutions Experiences Explosive Corporate Growth 2HYPR Corp. Addresses Android Vulnerability That Exposes Ecosystem-wide Biometric Security Challenges 2HYPR Corp. Addresses Android Vulnerability That Exposes Ecosystem-wide Biometric Security Challenges 3FPC's Touch Fingerprint Sensor FPC1155 in ZUK's Smartphone Z1 2
... a trait which could be exploited in lands affected by ... the Society for Experimental Biology meeting on July 5, shows ... outer layer of their roots are more efficient at accessing ... Jonathan Lynch at the Pennsylvania State University, United States, found ...
... ITHACA, N.Y. With fewer than a dozen flowering plants ... caloric intake, people need to tap unused plants to feed ... geneticist Susan McCouch in the Comment feature of the July ... with population growth and rising incomes around the world, researchers ...
... TORONTO - A team of Toronto-based researchers may be one ... cells for use in research and therapy. Induced pluripotent ... research because they can flexibly develop into many different types ... proteins that control their generation are largely unknown. But ...
Cached Biology News:To feed the future, we must mine the wealth of the world's seed banks today 2Toronto team ID proteins key in stem cell production 2
(Date:8/26/2015)... 26, 2015  Platform therapeutic company Symic Biomedical, ... a $1.5M Phase II SBIR grant from the ... its therapeutic agent to reduce arteriovenous fistula (AVF) ... stage renal disease (ESRD) patients undergoing hemodialysis. The ... Diabetes and Digestive and Kidney Diseases (NIDDK), will ...
(Date:8/26/2015)... BEIJING , August 26, 2015 Israel ... DiaCardio wins 1 st place  Wayerz comes ... in Israel by venture capital fund JVP, ... including the US, China , Israel ... America .  Impressive achievement for the Israeli representatives ...
(Date:8/26/2015)... 26, 2015 After litigating and negotiating ... relating to P2i United States patent ... in the United States without any ... of either party. As a result of the parties, settlement, ... California dismissed the case without prejudice. ...
(Date:8/26/2015)... ... August 26, 2015 , ... PRC Clinical, a Clinical Trial ... with local sponsors in southern California. The Clinical Trial Management Expert CRO seeks to ... regulatory pathways., , Stem Cell Meeting on the Mesa ...
Breaking Biology Technology:Symic Biomedical Awarded $1.5MM NIH Phase II SBIR Grant to Develop its Proteoglycan Mimetic Therapeutics to Reduce Vascular Access Failures in ESRD 2Symic Biomedical Awarded $1.5MM NIH Phase II SBIR Grant to Develop its Proteoglycan Mimetic Therapeutics to Reduce Vascular Access Failures in ESRD 3Israeli Startup Takes First Place at Shengjing Global Innovation Awards 2015 2Israeli Startup Takes First Place at Shengjing Global Innovation Awards 2015 3Israeli Startup Takes First Place at Shengjing Global Innovation Awards 2015 4Israeli Startup Takes First Place at Shengjing Global Innovation Awards 2015 5Israeli Startup Takes First Place at Shengjing Global Innovation Awards 2015 6P2i Settles United States Litigation 2PRC Clinical To Attend Major Industry Conferences And Meet Sponsor Companies In The San Diego Biotech Hub 2PRC Clinical To Attend Major Industry Conferences And Meet Sponsor Companies In The San Diego Biotech Hub 3
... Webcast to Be Held Today at 5:00 p.m. ET (22:00 CET), 2007 ... - Naglazyme net product revenue of $86.2 million, an increase of ... range of $82 million to $84 million, ... 28.5 percent over 2006 and toward the upper ...
... Recommend Pharmion ... with Celgene Special Meeting of ... Urges All Shareholders to Vote FOR the Proposed Merger, ... today announced that Institutional Shareholder Services,(ISS) has recommended that Pharmion ...
... in February issue of Clinical and Vaccine Immunology, ... and the University of Michigan have demonstrated their nasally,delivered ... lethal dose of smallpox, and without the safety risks ... smallpox virus,and builds immunity against it., The new ...
Cached Biology Technology:BioMarin Announces Fourth Quarter and Full Year 2007 Financial Results 2BioMarin Announces Fourth Quarter and Full Year 2007 Financial Results 3BioMarin Announces Fourth Quarter and Full Year 2007 Financial Results 4BioMarin Announces Fourth Quarter and Full Year 2007 Financial Results 5BioMarin Announces Fourth Quarter and Full Year 2007 Financial Results 6BioMarin Announces Fourth Quarter and Full Year 2007 Financial Results 7BioMarin Announces Fourth Quarter and Full Year 2007 Financial Results 8BioMarin Announces Fourth Quarter and Full Year 2007 Financial Results 9BioMarin Announces Fourth Quarter and Full Year 2007 Financial Results 10BioMarin Announces Fourth Quarter and Full Year 2007 Financial Results 11ISS Recommends Pharmion Shareholders Vote for Merger With Celgene 2ISS Recommends Pharmion Shareholders Vote for Merger With Celgene 3Nasal Vaccine for Smallpox Confers High Levels of Immunity Without Safety Risks 2Nasal Vaccine for Smallpox Confers High Levels of Immunity Without Safety Risks 3
... These handy dispensers save space ... wipers, hats, and other garb. ... storage bins for small parts ... manufacturing. Clear acrylic. Open-slot design ...
... is critical to the maintenance of ... proteins as important and diverse as ... shock and stress response, antigen presentation, ... ion channels, cell cycle regulation, transcription, ...
... The LIBS-ELITE houses Ocean Optics LIBS2000+ Spectrometers ... Universal Platform (UP) Ablation Chamber to offer ... control. The systems features include a high-power ... targeting functions, precise X-Y sample positioning, laser ...
... whole-blood clinical diagnostic work in hospitals and ... analyzer makes precise glucose measurements of whole ... measurements of whole blood, plasma, or cerebrospinal ... you to have glucose results expressed as ...
Biology Products: